Abiopharma

França concede acesso compassivo (AAC) reembolsável ao BOT/BAL da Agenus no câncer colorretal metastático MSS refratário

Francia otorga acceso compasivo (AAC) reembolsado para el tratamiento BOT/BAL de Agenus en el cáncer colorrectal metastásico refractario con MSS

La Francia concede laccesso compassionevole (AAC) rimborsato per BOT/BAL di Agenus nel tumore colorettale metastatico MSS

法國核准Agenus的BOT/BAL用於難治性MSS轉移性大腸癌的同情用藥報銷(AAC)

フランス、難治性MSS転移性大腸がんにおけるアジーナスのBOT/BALに償還付きコンパッショネートアクセス（AAC）を承認

法国批准Agenus的BOT/BAL用于难治性MSS转移性结直肠癌的同情用药报销(AAC)

Frankrijk verleent vergoede compassionate access (AAC) voor BOT/BAL van Agenus bij refractaire MSS-gemetastaseerde colorectale kanker

La France accorde une autorisation daccès compassionnel remboursable au BOT/BAL d’Agenus dans le cancer colorectal métastatique MSS réfractaire

FDA approve BIMATOPROST

Everything Announced at Apple’s “Awe Dropping” Event — iPhone 17, iOS 26, Apple Watch Ultra 3

New Form 424B3 - Beyond Air, Inc. Filed: 2025-09-09 AccNo: 0001493152-25-012867 Size: 263 KB

New Form 8-K - Beyond Air, Inc. Filed: 2025-09-09 AccNo: 0001493152-25-012866 Size: 465 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 6-K - SMITH & NEPHEW PLC Filed: 2025-09-09 AccNo: 0001654954-25-010536 Size: 31 KB

New SEC Filing for Avanos Medical Inc. (NYSE:AVNS)

New Form 6-K - SMITH & NEPHEW PLC Filed: 2025-09-09 AccNo: 0001654954-25-010532 Size: 31 KB